Dr Janet Woodcock on the FDA’s new Breakthrough designation

In Orphan Drug Congress by Tim PeplowLeave a Comment

Janet Woodcock, MD, Director of the FDA’s CDER drug division discusses the FDA’s new Breakthrough Designation for new drug approvals. Source: CurrentMedicine.TV

 

Leave a Comment